1. Submission
2. Aims and Scope
3. Manuscript Categories and Requirements
4. Preparing Your Submission
5. Editorial Policies and Ethical Considerations
6. Author Licensing
7. Publication Process after Acceptance
8. Post Publication
9. Editorial Office Contact Details
Thank you for your interest in Precision Medical Sciences. Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/prm2.
The submission system will prompt you to use an ORCID iD (a unique author identifier) to help distinguish your work from that of other researchers. Click here to find out more.
Click here for more details on how to use ScholarOne.
For help with submissions, please contact the Editorial Office at [email protected] .
We look forward to your submission.
Precision Medical Sciences is an international and peer-reviewed open access journal that covers all areas of clinical and translational research for precision medicine, especially in the field of oncology. The journal publishes basic and clinical trials studies which aim to promote personalized medicine, including novel technologies of cancer diagnosis, new drugs and molecule-targeted agents evaluation, innovative tumor therapy and researches on pharmacology and mechanisms of oncogenesis, progression and metastasis of malignant cancers.
Precision Medical Sciences is owned by Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital, published by John Wiley & Sons Australia, Ltd.
Keywords: Precision Medicine, Oncology, Clinical Medicine, Accurate Diagnosis, Individualized Therapy
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
(1) Original Articles
Word limit: 3,000 words maximum including abstract but excluding references, tables and figures.
Abstract: 250 words maximum, with sub-headers, Introduction, Methods, Results, Discussion.
References: no limit.
Figures/ tables: no limit, but 8 figures should be sufficient.
Description: Full-length reports of current research in either basic or clinical science.
(2) Review Articles
Word limit: 4,000 words maximum including abstract but excluding references, tables and figures.
Abstract: 250 words maximum.
References: no limit.
Figures/tables: minimum 1 image or figure.
Description: Reviews are comprehensive analyses of specific topics. They are submitted upon invitation by the Editors. Proposals for reviews may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.
(3) Case Reports
Word limit: 1,000 words maximum including abstract but excluding references, tables and figures.
Abstract: not required.
References: 20 maximum.
Figures/ tables: 4 maximum.
Description: New observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in Precision Medical Sciences. The text should be arranged as follows: Introduction, Case Report, Discussion. Only cases of exceptional interest and novelty are considered. For manuscripts that do not qualify, Editors may ask authors to shorten manuscripts and rewrite them as Letters to the Editor.
(4) Letters to the Editor
Word limit: 500 words maximum.
Abstract: not required.
References: 5 maximum.
Figures/ tables: 1 maximum.
Description: Letters must offer perspective to content published in Precision Medical Sciences. A Letter must reference the original source, and a Response to a Letter must reference the Letter in the first few paragraphs. Letters can use an arbitrary title, but a Response must cite the title of the Letter: e.g. Response to [title of Letter]. This ensures that readers can track the line of discussion.
(5) Editorials [only by invitation of Editors]
Word Limit: 1,500 words maximum.
Abstract: not required.
References: 5 maximum.
Description: Proposals for Editorials may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.
(6) Commentaries [only by invitation of Editors]
Word limit: 1,500 words maximum including abstract but excluding references.
Title: 20 words maximum.
Abstract: not required.
References: 20 maximum, including the article discussed.
Figures/tables: 2 maximum.
Description: Commentaries discuss a paper published in a specific issue and should set the problems addressed by the paper in the wider context of the field.
(7) Research Highlights
Word limit: 2,000 words maximum including abstract but excluding references: 3–4 brief summaries on recent research of 200–500 words each.
Title: 20 words maximum.
Abstract: not required.
References: 20 maximum, including the articles discussed.
Figures/tables: 2 maximum.
Description: Research Highlights discuss a number of recent original research papers, summarizing and commenting on each paper to give readers a real sense of the cutting edge of research in the field.
(8) Short Communications
Word limit: 1,500 words including abstract but excluding references, tables and figures.
Abstract: 250 words, unstructured (no use of sub-headers).
References: 35 maximum.
Figures/tables: 4 maximum.
Description: New findings that will substantially and immediately affect research or clinical practice. The words “Short Communication” must appear at the top left corner of the title page. Arrange text as in Original Articles.
(9) Clinical Guidelines
Word limit: 5,000 words maximum including abstract but excluding references, tables and figures.
Abstract: 250 words maximum.
References: no limit.
Figures/tables: minimum 1 image or figure.
Description: Guidelines need to be the product of a large group of individuals who are recognized as authorities in their field. Guidelines will be written by a working party to include a steering committee (usually at least 4 members) and other authors representing a wide range of those with special relevant expertise as well as those whose everyday practice will be influenced by the guidelines.
(10) Meeting Reports
Word limit: 3,000 words maximum including abstract but excluding references, tables and figures.
Abstract: 250 words maximum, with unstructured sub-headers.
References: no limit.
Figures/ tables: no limit, but 8 figures should be sufficient.
Description: Brief reports of symposia and conferences in geriatrics research. Reports must be submitted within 2 months of the meeting date in order to maintain their timeliness. Only those Meeting Reports dealing with topics of interest to the readership and that contain novel information and insights from the meeting are accepted for publication. A Meeting Report should be a thoughtful, critical commentary that shows an appreciation of the connections among the various presentations and reveals the consensus, if any, which emerged at the meeting. Before submitting a Meeting Report for consideration, potential authors must send a letter to the Editor-in-Chief inquiring whether the topic meets the criteria for consideration. Letters of inquiry should be sent to the Editorial Office (Email: [email protected]).
(11) Technical Notes
Word limit: 1,500 words including abstract but excluding references, tables and figures.
Abstract: 250 words, unstructured (no use of sub-headers).
References: 35 maximum.
Figures/tables: 4 maximum.
Description: Technical notes articles should present a new experimental or improved method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.
Word limit: 5000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, with sub-headers of Introduction, Methods, Discussion. Registration details (trial registration number and date of registration) should be included as the last line, if appropriate. References: no limit. Figures/tables: no limit, but 8 figures should be sufficient.
Description: Protocol papers should report planned or ongoing studies. Manuscripts describing long-term studies and those likely to generate a considerable amount of outcome data are given preference. The following protocol papers are not considered: (a) Manuscripts that report work already carried out. (b) Authors have other articles relating to the protocol published or under consideration. (3) Protocol papers for pilot or feasibility studies (4) Protocol papers without ethics approval.
Peer Review: Precision Medical Sciences will consider publishing without peer review protocols that have formal ethics approval and a grant from a recognized major funding body. Please provide proof that these criteria are met when uploading your protocol. Manuscripts without major external funding, or where the Editor considers it necessary, will be peer reviewed. The final decision on whether to consider a study protocol for publication will rest with the Editor.
Randomized trials: Protocols of randomized trials should follow the SPIRIT guidelines, including the SPIRIT flow diagram in the main body of the text, with the populated checklist provided as an additional file.
Parts of the Manuscript
The manuscript should be submitted in separate files: title page; main text file; figures.
The main text file should be presented in the following order: (i) title, abstract and keywords, (ii) main text, (iii) references, (iv) tables (each table complete with title and footnotes) (v) figure legends, (vi) appendices (if relevant). Figures and supporting information should be supplied as separate files.
Title page
The title page should contain:
(i) a short informative title that contains the major keywords. The title should not contain abbreviations (see Wiley's best practice SEO tips);
(ii) a short running title of less than 40 characters;
(iii) the full names of the authors;
(iv) the author's institutional affiliations at which the work was carried out;
(v) acknowledgements.
The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
Authorship
Please refer to the journal’s authorship policy in the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.
Acknowledgements
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgements section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.
Conflict of Interest Statement
You will be asked to provide a conflict of interest statement during the submission process. See the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section for details on what to include in this section. Please ensure you liaise with all co-authors to confirm agreement with the final statement.
Abstract
Please provide an abstract of no more than 250 words containing the major keywords. The abstract should adhere to the word count specifications under the section Manuscript Categories and Requirements. It should state the main problem, methods, results, and conclusions. It must be factual and comprehensive. The use of abbreviations and acronyms should be limited and general statements (e.g. ‘‘the significance of the results is discussed’’) should be avoided.
Keywords
Please provide three to five keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at https://www.nlm.nih.gov/mesh/.
Text
Authors should use the subheadings required for the Article Type as specified in the section 'Manuscript Categories and Requirements'. Original Article manuscripts should be structured using the following sections: Introduction, Methods, Results, Discussion, Acknowledgments, Disclosure, References, and when relevant, Supplementary Material.
References
The American Medical Association (AMA) system of referencing should be used. Please see the AMA Manual of Style for details. All references should be numbered consecutively in the order of appearance and should be as complete as possible. In-text citations, authors should cite references in consecutive order using Arabic superscript numerals. Sample references as follows:
In-Text examples:
Diabetes mellitus is associated with a high risk of foot ulcers.1-3
Several interventions have been successful at increasing compliance.11,14-16
The data of Smith et al18 is further evidence of this effect.
As reported previously,1,3-6
The results were as follows4:
Journal article (1-6 authors):
1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.
Journal article with more than six authors:
2. Geller AC, Venna S, Prout M, et al. Should the skin cancer examination be taught in medical school? Arch Dermatol. 2002;138(9):1201-1203.
Journal article with no named author or group name:
3. Centers for Disease Control and Prevention (CDC). Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use--Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2010;59(9):273.
Online articles not yet published in an issue:
4. Smith JJ, Fihn SD, White RH. Treatment of allergic rhinitis. Am J Med. In press; doi:10.1016/S0002-9343(00)00545-3.
Book:
5. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.
Book chapter:
6. Guyton JL, Crockarell JR. Fractures of acetabulum and pelvis. In: Canale ST, ed. Campbell's Operative Orthopaedics. 10th ed. Philadelphia, PA: Mosby, Inc; 2003:2939-2984.
Electronic book:
7. Rudolph CD, Rudolph AM. Rudolph's Pediatrics. 21st ed. New York, NY: McGraw-Hill Companies; 2002. http://online.statref.com/Document/Document.aspx?DocID=1&StartDoc=1&EndDoc=1882&FxID=13&offset=7&SessionId=A3F279FQVVFXFSXQ. Accessed August 22, 2007.
Internet document:
8. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed March 3, 2003.
Please note that journal title abbreviations should conform to the practices of Chemical Abstracts.
Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Preparing Figures
We encourage authors to send us the highest-quality figures possible. Resolution for graphs including line art needs to be 600-1000 dpi and must be eligible when reviewed as an 80mm or 1800 pixel width, unmagnified. Larger fonts are recommended for easier reading. The minimum resolution for general images is 300dpi. Authors may be asked to resubmit figures during submission or post acceptance if figures submitted with manuscripts don’t meet our requirements. Click here for the basic requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.Figure Legends
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.Appendices
Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.
Supporting Information
Supporting information is information that is not essential to the article but that provides greater depth and background. It is hosted online, and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on supporting information.
Note, if data, scripts or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.
Graphical Abstract/Graphical TOC
The journal’s table of contents will be presented in graphical form with a brief abstract for original articles and review articles, in addition to the up to 250 words abstract above. The online Graphical Abstract/TOC includes a schematic figure that best represents the scope of the paper, alongside a brief abstract summarizing the key findings presented in the paper. Authors should submit a stand-alone and original image to be displayed in the Graphical TOC, or designate an image already included in the article. The image supplied should conform to standard figure requirements and fit within the dimensions of 50mm x 60mm and be fully legible at this size. Text labels in the graphic should be limited and long sentences should be avoided. Your brief abstract should consist of 50-60 words or 2-3 sentences. Table of contents entries should be submitted to ScholarOne as ‘Graphical Abstract’ during the initial manuscript submission process and will be reviewed by editors.
General Style Points
The following links provide general advice on formatting and style.
Wiley Author Resources
Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.
Article Preparation Support
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Editorial Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
Wiley's policy on confidentiality of the review process is available here.
Manuscripts are assigned sequentially to Associate Editors. An Associate Editor solicits reviewers (typically, two external reviews are sought). The reviewers’ evaluations and Associate Editor’s comments are compiled by the Editor-in-Chief for disposition and transmittal to the authors.
The Editor-in-Chief will advise authors whether a manuscript is accepted, should be revised or is rejected. Minor revisions are expected to be returned within four weeks of decision; major revisions within three months. Manuscripts not revised within these time periods are subject to withdrawal from consideration for publication unless the authors can provide extenuating circumstances.
A number of manuscripts will have to be rejected on the grounds of priority and available space. A manuscript may be returned to the authors without outside review if the Editor-in-Chief and Associate Editor find it inappropriate for publication in the Journal.
The Editor-in-Chief’s decision is final. If, however, authors dispute a decision and can document good reasons why a manuscript should be reconsidered, a rebuttal process exists. In the first place, authors should write to the Editor-in-Chief.
If the journal receives a paper authored by an Editorial Board member (including the EiC), then in accordance with the journal’s peer-review policy, the concerned Editor will be strictly blinded from the internal editorial and peer-review processes related to that paper.
Precision Medical Sciences employs a plagiarism detection system. By submitting your manuscript to this journal, you accept that your manuscript may be screened for plagiarism against previously published works.
Data storage and documentation
Precision Medical Sciences encourages data sharing wherever possible, unless this is prevented by ethical, privacy or confidentiality matters. Authors publishing in the journal are therefore encouraged to make their data, scripts and other artefacts used to generate the analyses presented in the paper available via a publicly available data repository, however this is not mandatory. If the study includes original data, at least one author must confirm that he or she had full access to all the data in the study, and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Human Studies and Subjects
For manuscripts reporting medical studies involving human participants, we require a statement identifying the ethics committee that approved the study, and that the study conforms to recognized standards, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice.
Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher, however in signing the author license to publish authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use. The Chinese version is also available.
Animal Studies
A statement indicating that the protocol and procedures employed were ethically reviewed and approved, and the name of the body giving approval, must be included in the Methods section of the manuscript. We encourage authors to adhere to animal research reporting standards, for example the ARRIVE reporting guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines and regulations for the care and use of laboratory animals:
US authors should cite compliance with the US National Research Council's Guide for the Care and Use of Laboratory Animals, the US Public Health Service's Policy on Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory Animals.
UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).
European authors outside the UK should conform to Directive 2010/63/EU.
Clinical Trial Registration
We require that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Please include the name of the trial register and your clinical trial registration number at the end of your abstract. If your trial is not registered, or was registered retrospectively, please explain the reasons for this.
Research Reporting Guidelines
Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. We encourage authors to adhere to the following research reporting standards.
CONSORT guidelines for reports of randomized trials and cluster randomized trials
STROBE statement for observational studies (cohort, case–control, or cross-sectional designs)
STARD guidelines for studies of diagnostic accuracy
PRISMA guidelines for systematic reviews and meta-analyses: Complete PRISMA checklist
COREQ guidelines for qualitative studies: Complete COREQ checklist
See http://www.equator-network.org/ for other study types.
Conflicts of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. If the author is a member of the journal’s editorial board, it must be stated in the Conflict of Interest that ‘Dr. xxx is a member of Precision Medical Sciences editorial board’. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.
Funding
Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://support.crossref.org/hc/en-us/articles/214360886-The-Open-Funder-Registry.
Authorship
The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.
Additional authorship options
Joint first or senior authorship: In the case of joint first authorship a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’
Wiley’s Author Name Change Policy
In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.
Correction to authorship
In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Precision Medical Sciences will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]
ORCID
As part of our commitment to supporting authors at every step of the publishing process, Precision Medical Sciences requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information.
Publication Ethics
This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly (https://publicationethics.org/core-practices). Note this journal uses iThenticate’sCrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read our Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found at https://authorservices.wiley.com/ethics-guidelines/index.html.
Precision Medical Sciences is an Open Access journal, all articles will be published under the terms of the Creative Commons Attribution License which allows users to copy, distribute and transmit an article, adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed. Copyright on any research article published by a Wiley Open Access journal is retained by the author(s).
Authors grant Wiley a license to publish the article and identify itself as the original publisher.
The following license agreements are available:
Creative Commons Attribution (CC-BY) License
Creative Commons Attribution Non-Commercial (CC-BY-NC) license
Creative Commons Attribution-Non-Commercial-NoDerivs (CC-BY-NC-ND) license
If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
To learn more about Creative Commons Licenses and to preview terms and conditions of the agreements, please click here. Note that certain funders mandate that a particular type of CC license has to be used; to check this, please click here.
Open Access fees: submissions will be subject to an APC if accepted and published in the journal: $2400 USD / £1765 GBP / €2081 EUR. For more information on this journal’s APCs, please see the Open Access page.
7. PUBLICATION PROCESS AFTER ACCEPTANCE
Accepted article received in production
When your accepted article is received by Wiley’s production team, you (corresponding author) will receive an email asking you to login or register with Author Services. You will be asked to sign a publication license at this point.
Proofs
Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, all common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.
Early View
The journal offers rapid publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before your article appears online, as Editors also need to review proofs. Once your article is published on Early View no further changes to your article are possible. Your Early View article is fully citable and carries an online publication date and DOI for citations.
Access and sharing
When your article is published online:
You can now order print copies of your article at www.sheridan.com/wiley/eoc.
Now is the time to start promoting your article. Find out how to do that here.
Article Promotion Support
Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.
Measuring the Impact of your Work
Wiley also helps you measure the impact of your research through our specialist partnerships with Kudos and Altmetric.
9. EDITORIAL OFFICE CONTACT DETAILS
Precision Medical Sciences Editorial Office
Dr. Yin Rong
Managing Editor
No. 42 Baiziting, Nanjing, China
Email: PMSEditor@jszlyy.com.cn
Author Guidelines updated Mar 2022.